Pharmacodynamic modeling of the evolution of levofloxacin resistance in Staphylococcus aureus - sprookjes - yvandenbroek - TriplyDB

Pharmacodynamic modeling of the evolution of levofloxacin resistance in Staphylococcus aureus

Pharmacodynamic modeling of the evolution of levofloxacin resistance in Staphylococcus aureus

http://www.wikidata.org/entity/Q33836597

about

Mechanism-based pharmacodynamic models of fluoroquinolone resistance in Staphylococcus aureus.Mutant selection window hypothesis updated.Quantifying subpopulation synergy for antibiotic combinations via mechanism-based modeling and a sequential dosing design Pharmacokinetic/pharmacodynamic analysis of the influence of inoculum size on the selection of resistance in Escherichia coli by a quinolone in a mouse thigh bacterial infection model Quinolones: action and resistance updated.In vitro pharmacodynamic models to determine the effect of antibacterial drugs.Translational PK/PD of anti-infective therapeutics.Influence of inoculum size and marbofloxacin plasma exposure on the amplification of resistant subpopulations of Klebsiella pneumoniae in a rat lung infection model.

P2860

Q35023303-E3E68A81-21C6-4257-AC54-246977344F56 Q36728061-A9B3ECD3-C10F-401A-874A-09D6C519D710 Q36785827-C0F85D7E-3D40-4457-BB35-8DA45F44A47E Q37274635-52B6752C-D896-4E1E-8833-1A3E81200640 Q37595559-51ED4474-F00A-422D-8A97-DD983B54F694 Q37660762-321ECA5C-64D2-4FFD-BFB1-D5B929EF2837 Q39039505-44FCFEEE-48A6-48C1-B1D0-3DFFF5CEC162 Q42612081-BED02DCB-0EDE-4558-A637-A425B312A45A

P2860

Pharmacodynamic modeling of the evolution of levofloxacin resistance in Staphylococcus aureus

http://www.wikidata.org/entity/Q33836597

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Pharmacodynamic modeling of th ...... tance in Staphylococcus aureus

@ast

Pharmacodynamic modeling of th ...... tance in Staphylococcus aureus

@en

type

label

Pharmacodynamic modeling of th ...... tance in Staphylococcus aureus

@ast

Pharmacodynamic modeling of th ...... tance in Staphylococcus aureus

@en

prefLabel

Pharmacodynamic modeling of th ...... tance in Staphylococcus aureus

@ast

Pharmacodynamic modeling of th ...... tance in Staphylococcus aureus

@en

P1433

Q33836597-CA9D30BE-524A-41EB-A5A9-282576A93484

P1476

Q33836597-2C530AB0-1759-41EB-8B5F-74182DDD48D9

P2093

Q33836597-1E413151-9597-4D65-9FE9-DDF0E07227B9

Q33836597-96386C24-2417-4260-B30A-AD65A4A8547D

Q33836597-B96DC3C3-642D-4525-BABC-C153622EE325

Q33836597-E127329F-AB27-420E-B9F2-A09AA630C7A4

Q33836597-E3D09701-1C2A-43E8-8E60-F7D7762DE421

P2860

Q33836597-064F3BC2-CCF8-44DB-9CBF-243776187FFF

Q33836597-0A8F9650-1F5B-4C4F-BE7D-B6A42CBFDC74

Q33836597-0EFAF468-9762-4DFE-9926-DF448A06F9AE

Q33836597-1287FB07-499A-4ECF-9A1D-5D945F8ED124

Q33836597-16EF2B0E-D13B-4F04-99D6-16F8AA3E882B

Q33836597-1A68CAAC-0A75-417D-92AC-D9CA8CD890F9

Q33836597-40BA7170-C438-4657-8228-C5D3FDAE8229

Q33836597-449E5A13-36BB-47D9-9CBB-F7167366C35A

Q33836597-512337D6-D6CC-4BA8-95E4-8EEBDDEE9CC8

Q33836597-5A1105B8-A681-409D-A273-BF4DE4D9D412

P304

Q33836597-E0EE4C93-34F2-4261-BFE9-22973EA66064

P31

Q33836597-C35148B8-E8C2-4DDE-9F11-79F0B3DA0D05

P356

Q33836597-9F02D891-25D2-4A04-B0BC-6ABC1CC988C0

P407

Q33836597-E8CE120B-54F7-49E5-8ED4-B3ABC8D46393

P433

Q33836597-5EB88DD6-CF0F-42B2-BA8D-C3C8C7BB65E2

P478

Q33836597-A3EABC99-03D6-47F5-92D7-F8B19136B33D

P577

Q33836597-6281C99D-5F22-48D3-8FB4-61B2ED60EC63

P5875

Q33836597-81ACE0E8-DCC4-4E87-9A85-0A1A28282A3B

P698

Q33836597-E2934485-AE91-4E12-A588-4072EE4CE272

P932

Q33836597-2B2C3FA9-23BD-439F-A11B-871EDF295A6E

P356

AAC.49.6.2189-2199.2005

P1433

Antimicrobial Agents and Chemotherapy

P1476

Pharmacodynamic modeling of th ...... tance in Staphylococcus aureus

@en

P2093

Jeffrey J Campion

http://www.w3.org/2001/XMLSchema#string

Martin E Evans

http://www.w3.org/2001/XMLSchema#string

Patrick J McNamara

http://www.w3.org/2001/XMLSchema#string

Philip Chung

http://www.w3.org/2001/XMLSchema#string

William B Titlow

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular diversity of quinolone resistance in genetically related clinical isolates of Staphylococcus aureus and susceptibility to newer quinolones.

Pharmacodynamic modeling of ciprofloxacin resistance in Staphylococcus aureus.

Characterization of grlA, grlB, gyrA, and gyrB mutations in 116 unrelated isolates of Staphylococcus aureus and effects of mutations on ciprofloxacin MIC.

Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin

Safety and pharmacokinetics of multiple 750-milligram doses of intravenous levofloxacin in healthy volunteers.

Bactericidal activities of BMS-284756, a novel Des-F(6)-quinolone, against Staphylococcus aureus strains with topoisomerase mutations.

Activity of BMS-284756, a novel des-fluoro(6) quinolone, against Staphylococcus aureus, including contributions of mutations to quinolone resistance

Pharmacokinetic-pharmacodynamic modeling of activity of ceftazidime during continuous and intermittent infusion.

Mechanisms of fluoroquinolone resistance in genetically related strains of Staphylococcus aureus

Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy.

P304

2189-2199

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.49.6.2189-2199.2005

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P577

2005-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7823295

http://www.w3.org/2001/XMLSchema#string

P698

15917512

http://www.w3.org/2001/XMLSchema#string

P932

1140504

http://www.w3.org/2001/XMLSchema#string